ENTERIX INC. FDA Inspection Record
ENTERIX INC. is an FDA-registered facility (FEI 3003224146) located in EDISON, NJ, US. RegDataLab tracks 5 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Aug 10, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 5 (1 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 2, latest Sep 17, 2025
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Aug 10, 2026 | Voluntary Action Indicated (VAI) | Risk-based approach not applied to QMS processes (ISO 13485:2016 Clause 4.1.2) Feedback process procedures not documented (ISO 13485:2016 Clause 8.2.1) Corrective action not taken (ISO 13485:2016 Clause 8.5.2) |
| Mar 10, 2023 | No Action Indicated (NAI) | Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Lack of or inadequate procedures (21 CFR 820.100(a)) Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a)) Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a)) |
| Aug 18, 2016 | No Action Indicated (NAI) | No citations listed |
| Nov 27, 2012 | No Action Indicated (NAI) | No citations listed |
| Jul 1, 2010 | No Action Indicated (NAI) | Lack of or inadequate procedures (21 CFR 820.100(a)) DMR - not or inadequately maintained (21 CFR 820.181) Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Sep 17, 2025 | Class II | Z-0725-2026 | InSure ONE Fecal Immunochemical Test. Labeled as follows:
1. Insure ONE POL Patient Kit… InSure ONE failed sensitivity testing when used with Test Card Lot T241102, which may result in false negative results. |
| Oct 8, 2020 | Class II | Z-0590-2021 | InSure ONE Test Strips (25 pack) vials-fecal immunochemical test (FIT) qualitatively… Product does not meet internal testing criterion; use of the product may result in a potential false positive test result and may lead to… |
FDA record score
11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
3 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Aug 10, 2026 | 6 x 1 | 6 |
| Class II recall Z-0725-2026, this FEI as the recalling firm | Sep 17, 2025 | 4 x 1 | 4 |
| Class II recall Z-0590-2021, this FEI as the recalling firm | Oct 8, 2020 | 4 x 0.25 | 1 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing ENTERIX INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check ENTERIX INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Enterix, Inc.
- Location
- EDISON, NJ (US)
- Source
- device